Forbion in $450m pharma deal

The sale comes as Forbion is currently attempting to collect €150m for Fund III

5 August 2014•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.